DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
DCPH
Delisted
DCPH was delisted on the 10th of June, 2024.
145 hedge funds and large institutions have $792M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 54 increasing their positions, 43 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 146 → 145 (-1)
12% less capital invested
Capital invested by funds: $897M → $792M (-$104M)
Holders
145
Holding in Top 10
2
Calls
$264K
Puts
$218K
Top Buyers
| 1 | +$21M | |
| 2 | +$7.67M | |
| 3 | +$6.48M | |
| 4 |
Morgan Stanley
New York
|
+$6.15M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$5.7M |
Top Sellers
| 1 | -$21.1M | |
| 2 | -$13.1M | |
| 3 | -$10.5M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$9.91M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.33M |